Skip to main content
Equibles

Integrated Wealth Concepts LLC

Position in GALT — Galectin Therapeutics Inc

CIK 1737109 WALTHAM, MA
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$46,400
+$18,500 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 98 holders
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Integrated Wealth Concepts LLC holds $51,203,908 across 302 Biotechnology names. GALT ranks #79 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BMRN
Biomarin Pharmaceutical Inc
 152,216 $8,709,799
2 INVA
Innoviva, Inc.
 350,575 $7,961,558
3 EXEL
Exelixis, Inc.
 69,926 $3,804,673
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,994 $3,474,129
5 DNLI
Denali Therapeutics Inc.
 102,241 $2,629,638
6 ALNY
Alnylam Pharmaceuticals, Inc.
 6,692 $2,014,492
7 INCY
Incyte Corp
 17,318 $1,963,168
8 TLX
Telix Pharmaceuticals Ltd
 164,397 $1,895,497

All Filings in GALT

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $46,400 10,000
2026-03-31 $27,900 10,000
2025-09-30 $42,400 10,000
2025-06-30 $21,209 10,052
2025-03-31 $12,212 10,010
2024-12-31 $12,902 10,002
2024-09-30 $27,500 10,000
2024-06-30 $22,600 10,000
2024-03-31 $23,900 10,000
2023-12-31 $16,600 10,000
2023-09-30 $19,200 10,000
2023-06-30 $14,400 10,000
2023-03-31 $21,000 10,000